An RCT of ganciclovir prophylaxis for CMV disease in pediatric liver transplant recipients.

被引：0
|
作者：
King, SM
Superina, R
Andrews, W
Winston, D
Dunn, S
Colombani, P
机构：
[1] HOSP SICK CHILDREN,TORONTO,ON M5G 1X8,CANADA
[2] SW MED CTR,DALLAS,TX
[3] UNIV CALIF LOS ANGELES,LOS ANGELES,CA
[4] ST CHRISTOPHERS HOSP,PHILADELPHIA,PA
[5] JOHNS HOPKINS UNIV,BALTIMORE,MD
来源：
CLINICAL INFECTIOUS DISEASES | 1996年 / 23卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：243 / 243
页数：1
相关论文
共 50 条
  • [31] Valganciclovir for the prophylaxis of cytomegalovirus disease in pediatric liver transplant recipients
    Clark, BS
    Chang, IF
    Karpen, SJ
    Herrera, L
    Scott, JD
    Bristow, LJ
    Quirós-Tejeira, RE
    Goss, JA
    TRANSPLANTATION, 2004, 77 (09) : 1480 - 1480
  • [32] Growth of Liver Allografts in Pediatric Transplant Recipients.
    Chaudhry, S.
    Stern, J.
    Lobritto, S.
    Martinez, M.
    Vitorrio, J.
    Emond, J.
    Kato, T.
    Samstein, B.
    Bentley-Hibbert, S.
    Griesemer, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 768 - 768
  • [33] Persistent hyperglycemia in pediatric liver transplant recipients.
    Romero, R
    Melde, KJ
    Pillen, TJ
    Smallwood, GA
    O'Neill, CM
    Depaolo, JM
    Heffron, TG
    GASTROENTEROLOGY, 2001, 120 (05) : A562 - A562
  • [34] Centrilobular fibrosis in pediatric liver transplant recipients.
    Russo, P
    Martin, S
    Alvarez, F
    Dubois, J
    LABORATORY INVESTIGATION, 1999, 79 (01) : 5P - 5P
  • [35] Evolving experience of HBV prophylaxis in liver transplant recipients.
    Honaker, MR
    Shokkouh-Amiri, MH
    Alloway, RR
    Grewal, HP
    Hardinger, KL
    Kizilisik, TA
    Bagous, T
    Trofe, J
    Vera, SR
    Stratta, RJ
    Egidi, MF
    Gaber, AO
    TRANSPLANTATION, 2000, 69 (08) : S315 - S315
  • [36] Does valgan (ganciclovir hydrochloride) provide effective prophylaxis against cytomegaloviral (CMV) infection in liver transplant recipients?
    Jain, A
    Orloff, M
    Lansing, K
    Kashyap, R
    Mark, K
    Betts, R
    Menegus, M
    Bozorgzadeh, A
    JOURNAL OF HEPATOLOGY, 2004, 40 : 48 - 48
  • [37] Is CMV Prophylaxis Necessary in CMV Low-Risk Liver Transplant Recipients?
    Fleming, J. N.
    Bowman, L.
    Truscott, C.
    Pilch, N.
    Taber, D.
    Pote, L.
    Powderly, A.
    Mathur, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 474 - 474
  • [38] A prospective trial of valganciclovir prophylaxis for cytomegalovirus (CMV) prevention in lung transplant recipients.
    Humar, A
    Kumar, D
    Preiksaitis, J
    Fenton, J
    Nia, S
    Jackson, K
    Chernenko, S
    Lien, D
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 270 - 270
  • [39] Comparison of Prophylaxis Strategies for CMV Infection in Liver Transplant Recipients
    Schnelle, K.
    Leino, A.
    Chunduru, M.
    Von Stein, L.
    Witkowsky, O.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 789 - 789
  • [40] Emergence of clinically significant ganciclovir (GCV)- resistant strains of CMV in solid organ transplant recipients.
    Isada, CM
    Yen-Lieberman, B
    Kohn, D
    Mossad, SB
    Flechner, S
    Mawhorter, SD
    Taege, AJ
    Gordon, SM
    Maurer, J
    Schmitt, SK
    Goldman, MP
    Longworth, DL
    Avery, RK
    TRANSPLANTATION, 2000, 69 (08) : S181 - S181
12345